TherapeuticsMD (TXMD) Net Margin Growth (1y) (2012 - 2026)
Powered by 
Analysis
TherapeuticsMD (TXMD) Net Margin Growth (1y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | -146.00 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 1,518.00 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | -3,607.00 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | -610.00 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | -2,157.00 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 1,486.00 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | -3,647.00 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 673.00 |
| 10 | TherapeuticsMD | 25.35 Mn | 16.16 Mn | - | -4,004.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,004.00 |
| Mar 31, 2026 | 17,928.00 |
| Dec 31, 2025 | -12,810.00 |
| Sep 30, 2025 | 13,072.00 |
| Jun 30, 2025 | 55,147.00 |
| Mar 31, 2025 | 6,835.00 |
| Dec 31, 2024 | 24,683.00 |
| Sep 30, 2024 | 626,225.00 |
| Jun 30, 2024 | 5,881.00 |
| Mar 31, 2024 | 63,160.00 |
| Dec 31, 2023 | -29,779.00 |
| Sep 30, 2023 | 172,387.00 |
| Jun 30, 2023 | -3.26 Mn |
| Mar 31, 2023 | 618,728.00 |
| Dec 31, 2022 | -15,517.00 |
| Sep 30, 2022 | -791,081.00 |
| Jun 30, 2022 | 3.23 Mn |
| Mar 31, 2022 | -685,514.00 |
| Dec 31, 2021 | 45,490.00 |
| Sep 30, 2021 | -1,804.00 |